Symrise has completed the acquisition of roughly 90.2% of Probi shares. This acquisition follows the company’s announcement of a public offer, during which it secured an additional 321,620 shares of Probi at the highest price of SEK 350, representing a 2.8% increase in its ownership and voting power.
Probi’s second largest stakeholders, Fjarde AP-fonden and Moneta Asset Management, have agreed to back Symrise’s proposition. Their collective holdings amount to about 17.7% of the company’s outstanding capital and voting rights. The window for accepting the offer is slated to begin near December 18, 2024, and close around January 15, 2025.
In a statement, Symrise emphasized its longstanding engagement with Probi since 2012 and its comprehensive insight into the company. Highlighting Probi’s robust team and valuable probiotic products, Symrise sees an opportunity to drive Probi’s growth further, aligning with Symrise’s strategic focus on health advancement globally.